MCMV5322A/MCMV3068A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MCMV5322A/MCMV3068A, covering 2017-03-08 to 2017-03-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients [Phase 2]

See pricing